Trial intelligence / Profile preview

Long-term management of atopic dermatitis with emollient V0034 CR

2005-003396-21Phase 3Completed

Sponsor
Pierre Fabre Laboratories
Start
Aug 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of glycerol in atopic dermatitis (AD), sponsored by Pierre Fabre Laboratories. Primary endpoint: Number of days of application of a moderately potent corticosteroid. Started Aug 2005; status: completed.

02

Drugs

glycerol
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on 2005-003396-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003396-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call